Top

18-04-2018 | Osteoarthritis | Review | Article

Mitochondrial DNA variation and the pathogenesis of osteoarthritis phenotypes

Journal: Nature Reviews Rheumatology

Authors: Francisco J. Blanco, Ana M. Valdes, Ignacio Rego-Pérez

Publisher: Nature Publishing Group UK

Abstract

Mitochondria and mitochondrial DNA (mtDNA) variation are now recognized as important factors in the development of osteoarthritis (OA). Mitochondria are the energy powerhouses of the cell, and also regulate different processes involved in the pathogenesis of OA including inflammation, apoptosis, calcium metabolism and the generation of reactive oxygen species (ROS) and reactive nitrogen species (RNS). Mitochondria contain their own genetic material, mtDNA, which evolved through the sequential accumulation of mtDNA variants to enable humans to adapt to different climates. The ROS and reactive metabolic intermediates that are by-products of mitochondrial metabolism are regulated in part by mtDNA and are among the signals that transmit information between mitochondria and the nucleus. These signals can alter nuclear gene expression and, when disrupted, affect a number of cellular processes and metabolic pathways, leading to disease. mtDNA variation influences OA-associated phenotypes, including those related to metabolism, inflammation and even ageing, as well as nuclear epigenetic regulation. This influence also enables the use of specific mtDNA haplogroups as complementary diagnostic and prognostic biomarkers of OA.

Blanco, F. J., Rego, I. & Ruiz-Romero, C. The role of mitochondria in osteoarthritis. Nat. Rev. Rheumatol. 7, 161–169 (2011).PubMedCrossRef

Kraus, V. B., Blanco, F. J., Englund, M., Karsdal, M. A. & Lohmander, L. S. Call for standardized definitions of osteoarthritis and risk stratification for clinical trials and clinical use. Osteoarthritis Cartilage 23, 1233–1241 (2015).PubMedPubMedCentralCrossRef

Sellam, J. & Berenbaum, F. Is osteoarthritis a metabolic disease? Joint Bone Spine 80, 568–573 (2013).PubMedCrossRef

Blanco, F. J. & Rego-Pérez, I. Editorial: is it time for epigenetics in osteoarthritis? Arthritis Rheumatol. 66, 2324–2327 (2014).PubMedCrossRef

Berenbaum, F. Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!). Osteoarthritis Cartilage 21, 16–21 (2013).PubMedCrossRef

Mobasheri, A. & Batt, M. An update on the pathophysiology of osteoarthritis. Ann. Phys. Rehabil. Med. 59, 333–339 (2016).PubMedCrossRef

Minafra, L. et al. Genetic, clinical and radiographic signs in knee osteoarthritis susceptibility. Arthritis Res. Ther. 16, R91 (2014).PubMedPubMedCentralCrossRef

Wang, Y., Zhao, X., Lotz, M., Terkeltaub, R. & Liu-Bryan, R. Mitochondrial biogenesis is impaired in osteoarthritis chondrocytes but reversible via peroxisome proliferator-activated receptor γ coactivator 1α. Arthritis Rheumatol. 67, 2141–2153 (2015).PubMedPubMedCentralCrossRef

Henze, K. & Martin, W. Evolutionary biology: essence of mitochondria. Nature 426, 127–128 (2003).PubMedCrossRef

10.

Picard, M., Wallace, D. C. & Burelle, Y. The rise of mitochondria in medicine. Mitochondrion 30, 105–116 (2016).PubMedPubMedCentralCrossRef

11.

Shadel, G. S. & Horvath, T. L. Mitochondrial ROS signaling in organismal homeostasis. Cell 163, 560–569 (2015).PubMedPubMedCentralCrossRef

12.

Wallace, D. C. & Fan, W. Energetics, epigenetics, mitochondrial genetics. Mitochondrion 10, 12–31 (2010).PubMedCrossRef

13.

Wallace, D. C. Maternal genes: mitochondrial diseases. Birth Defects Orig. Artic. Ser. 23, 137–190 (1987).PubMed

14.

Torroni, A. et al. Classification of European mtDNAs from an analysis of three European populations. Genetics 144, 1835–1850 (1996).PubMedPubMedCentral

15.

Ruiz-Pesini, E., Mishmar, D., Brandon, M., Procaccio, V. & Wallace, D. C. Effects of purifying and adaptive selection on regional variation in human mtDNA. Science 303, 223–226 (2004).PubMedCrossRef

16.

Kwak, S. H. & Park, K. S. Role of mitochondrial DNA variation in the pathogenesis of diabetes mellitus. Front. Biosci. 21, 1151–1167 (2016).CrossRef

17.

Hudson, G. et al. Two-stage association study and meta-analysis of mitochondrial DNA variants in Parkinson disease. Neurology 80, 2042–2048 (2013).PubMedPubMedCentralCrossRef

18.

De Benedictis, G. et al. Mitochondrial DNA inherited variants are associated with successful aging and longevity in humans. FASEB J. 13, 1532–1536 (1999).PubMedCrossRef

19.

Niemi, A. K. et al. Mitochondrial DNA polymorphisms associated with longevity in a Finnish population. Hum. Genet. 112, 29–33 (2003).PubMedCrossRef

20.

Courtenay, M. D. et al. Mitochondrial haplogroup X is associated with successful aging in the Amish. Hum. Genet. 131, 201–208 (2012).PubMedCrossRef

21.

Wallace, D. C. Mitochondrial DNA variation in human radiation and disease. Cell 163, 33–38 (2015).PubMedPubMedCentralCrossRef

22.

Fang, H. et al. Role of mtDNA haplogroups in the prevalence of knee osteoarthritis in a southern Chinese population. Int. J. Mol. Sci. 15, 2646–2659 (2014).PubMedPubMedCentralCrossRef

23.

Shen, J. M., Feng, L. & Feng, C. Role of mtDNA haplogroups in the prevalence of osteoarthritis in different geographic populations: a meta-analysis. PLoS ONE 9, e108896 (2014).PubMedPubMedCentralCrossRef

24.

Soto-Hermida, A. et al. mtDNA haplogroups and osteoarthritis in different geographic populations. Mitochondrion 15, 18–23 (2014).PubMedCrossRef

25.

Fernández-Moreno, M. et al. A replication study and meta-analysis of mitochondrial DNA variants in the radiographic progression of knee osteoarthritis. Rheumatology 56, 263–270 (2017).PubMedCrossRef

26.

Fernández-Moreno, M. et al. Mitochondrial DNA haplogroups influence the risk of incident knee osteoarthritis in OAI and CHECK cohorts. A meta-analysis and functional study. Ann. Rheum. Dis. 76, 1114–1122 (2017).PubMedCrossRef

27.

Picard, M. et al. Mitochondrial functions modulate neuroendocrine, metabolic, inflammatory, and transcriptional responses to acute psychological stress. Proc. Natl Acad. Sci. USA 112, E6614–E6623 (2015).PubMedPubMedCentralCrossRef

28.

Wallace, D. C. Genetics: Mitochondrial DNA in evolution and disease. Nature 535, 498–500 (2016).PubMedCrossRefPubMedCentral

29.

Terkeltaub, R., Johnson, K., Murphy, A. & Ghosh, S. Invited review: the mitochondrion in osteoarthritis. Mitochondrion 1, 301–319 (2002).PubMedCrossRef

30.

Lee, R. B. & Urban, J. P. Evidence for a negative Pasteur effect in articular cartilage. Biochem. J. 321, 95–102 (1997).PubMedPubMedCentralCrossRef

31.

Maneiro, E. et al. Mitochondrial respiratory activity is altered in osteoarthritic human articular chondrocytes. Arthritis Rheum. 48, 700–708 (2003).PubMedCrossRef

32.

Kim, H. A. & Blanco, F. J. Cell death and apoptosis in osteoarthritic cartilage. Curr. Drug Targets 8, 333–345 (2007).PubMedCrossRef

33.

Hwang, H. S. & Kim, H. A. Chondrocyte apoptosis in the pathogenesis of osteoarthritis. Int. J. Mol. Sci. 16, 26035–26054 (2015).PubMedPubMedCentralCrossRef

34.

Vaamonde-García, C. et al. Mitochondrial dysfunction increases inflammatory responsiveness to cytokines in normal human chondrocytes. Arthritis Rheum. 64, 2927–2936 (2012).PubMedCrossRef

35.

Cillero-Pastor, B. et al. Mitochondrial dysfunction activates cyclooxygenase 2 expression in cultured normal human chondrocytes. Arthritis Rheum. 58, 2409–2419 (2008).PubMedCrossRef

36.

Cillero-Pastor, B., Rego-Perez, I., Oreiro, N., Fernandez-Lopez, C. & Blanco, F. J. Mitochondrial respiratory chain dysfunction modulates metalloproteases -1,-3 and -13 in human normal chondrocytes in culture. BMC Musculoskelet. Disord. 14, 235 (2013).PubMedPubMedCentralCrossRef

37.

Collins, J. A. et al. Oxidative stress promotes peroxiredoxin hyperoxidation and attenuates pro-survival signaling in aging chondrocytes. J. Biol. Chem. 291, 6641–6654 (2016).PubMedPubMedCentralCrossRef

38.

Blanco, F. J., Lopez-Armada, M. J. & Maneiro, E. Mitochondrial dysfunction in osteoarthritis. Mitochondrion 4, 715–728 (2004).PubMedCrossRef

39.

Henrotin, Y. & Kurz, B. Antioxidant to treat osteoarthritis: dream or reality? Curr. Drug Targets 8, 347–357 (2007).PubMedCrossRef

40.

Grishko, V. I., Ho, R., Wilson, G. L. & Pearsall, A. W. Diminished mitochondrial DNA integrity and repair capacity in OA chondrocytes. Osteoarthritis Cartilage 17, 107–113 (2009).PubMedCrossRef

41.

Farnaghi, S. et al. Protective effects of mitochondria-targeted antioxidants and statins on cholesterol-induced osteoarthritis. FASEB J. 31, 356–367 (2017).PubMedCrossRef

42.

Lotz, M. & Loeser, R. F. Effects of aging on articular cartilage homeostasis. Bone 51, 241–248 (2012).PubMedPubMedCentralCrossRef

43.

Gavriilidis, C., Miwa, S., von Zglinicki, T., Taylor, R. W. & Young, D. A. Mitochondrial dysfunction in osteoarthritis is associated with down-regulation of superoxide dismutase 2. Arthritis Rheum. 65, 378–387 (2013).PubMedCrossRef

44.

Ruiz-Romero, C. et al. Mitochondrial dysregulation of osteoarthritic human articular chondrocytes analyzed by proteomics: a decrease in mitochondrial superoxide dismutase points to a redox imbalance. Mol. Cell. Proteom. 8, 172–189 (2009).CrossRef

45.

Scott, J. L. et al. Superoxide dismutase downregulation in osteoarthritis progression and end-stage disease. Ann. Rheum. Dis. 69, 1502–1510 (2010).PubMedCrossRef

46.

Choi, A. M., Ryter, S. W. & Levine, B. Autophagy in human health and disease. N. Engl. J. Med. 368, 1845–1846 (2013).PubMedCrossRef

47.

López de Figueroa, P., Lotz, M. K., Blanco, F. J. & Caramés, B. Autophagy activation and protection from mitochondrial dysfunction in human chondrocytes. Arthritis Rheumatol. 67, 966–976 (2015).PubMedCrossRef

48.

Alvarez-Garcia, O. et al. Regulated in development and DNA damage response 1 deficiency impairs autophagy and mitochondrial biogenesis in articular cartilage and increases the severity of experimental osteoarthritis. Arthritis Rheumatol. 69, 1418–1428 (2017).PubMedCrossRefPubMedCentral

49.

Mishmar, D. et al. Natural selection shaped regional mtDNA variation in humans. Proc. Natl Acad. Sci. USA 100, 171–176 (2003).PubMedCrossRef

50.

Wallace, D. C. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu. Rev. Genet. 39, 359–407 (2005).PubMedPubMedCentralCrossRef

51.

Martínez-Redondo, D. et al. Human mitochondrial haplogroup H: the highest VO_2max consumer — is it a paradox? Mitochondrion 10, 102–107 (2010).PubMedCrossRef

52.

Pierron, D. et al. Mutation rate switch inside Eurasian mitochondrial haplogroups: impact of selection and consequences for dating settlement in Europe. PLoS ONE 6, e21543 (2011).PubMedPubMedCentralCrossRef

53.

Wallace, D. C., Brown, M. D. & Lott, M. T. Mitochondrial DNA variation in human evolution and disease. Gene 238, 211–230 (1999).PubMedCrossRef

54.

Chen, A., Raule, N., Chomyn, A. & Attardi, G. Decreased reactive oxygen species production in cells with mitochondrial haplogroups associated with longevity. PLoS ONE 7, e46473 (2012).PubMedPubMedCentralCrossRef

55.

Kenney, M. C. et al. Mitochondrial DNA variants mediate energy production and expression levels for CFH, C3 and EFEMP1 genes: implications for age-related macular degeneration. PLoS ONE 8, e54339 (2013).PubMedPubMedCentralCrossRef

56.

Kenney, M. C. et al. Inherited mitochondrial DNA variants can affect complement, inflammation and apoptosis pathways: insights into mitochondrial-nuclear interactions. Hum. Mol. Genet. 23, 3537–3551 (2014).PubMedCrossRef

57.

Chang, M. C. et al. Accumulation of mitochondrial DNA with 4977-bp deletion in knee cartilage — an association with idiopathic osteoarthritis. Osteoarthritis Cartilage 13, 1004–1011 (2005).PubMedCrossRef

58.

Chomyn, A. Platelet-mediated transformation of human mitochondrial DNA-less cells. Methods Enzymol. 264, 334–339 (1996).PubMedCrossRef

59.

van Gisbergen, M. W. et al. How do changes in the mtDNA and mitochondrial dysfunction influence cancer and cancer therapy? Challenges, opportunities and models. Mutat. Res. Rev. Mutat. Res. 764, 16–30 (2015).PubMedCrossRef

60.

Weng, S. W. et al. Study of insulin resistance in cybrid cells harboring diabetes-susceptible and diabetes-protective mitochondrial haplogroups. Mitochondrion 13, 888–897 (2013).PubMedCrossRef

61.

Fang, H. et al. Mitochondrial DNA haplogroups modify the risk of osteoarthritis by altering mitochondrial function and intracellular mitochondrial signals. Biochim Biophys. Acta 1862, 829–836 (2016).PubMedCrossRef

62.

Roubertoux, P. L. et al. Mitochondrial DNA modifies cognition in interaction with the nuclear genome and age in mice. Nat. Genet. 35, 65–69 (2003).PubMedCrossRef

63.

Yu, X. et al. Dissecting the effects of mtDNA variations on complex traits using mouse conplastic strains. Genome Res. 19, 159–165 (2009).PubMedPubMedCentralCrossRef

64.

Latorre-Pellicer, A. et al. Mitochondrial and nuclear DNA matching shapes metabolism and healthy ageing. Nature 535, 561–565 (2016).PubMedCrossRef

65.

Achilli, A. et al. Mitochondrial DNA backgrounds might modulate diabetes complications rather than T2DM as a whole. PLoS ONE 6, e21029 (2011).PubMedPubMedCentralCrossRef

66.

Rego-Perez, I., Fernandez-Moreno, M., Fernandez-Lopez, C., Arenas, J. & Blanco, F. J. Mitochondrial DNA haplogroups: role in the prevalence and severity of knee osteoarthritis. Arthritis Rheum. 58, 2387–2396 (2008).PubMedCrossRef

67.

Rego, I. et al. Role of European mitochondrial DNA haplogroups in the prevalence of hip osteoarthritis in Galicia, Northern Spain. Ann. Rheum. Dis. 69, 210–213 (2010).PubMedCrossRef

68.

Hudson, G. et al. No evidence of an association between mitochondrial DNA variants and osteoarthritis in 7393 cases and 5122 controls. Ann. Rheum. Dis. 72, 136–139 (2013).PubMedCrossRef

69.

Hannan, M. T., Felson, D. T. & Pincus, T. Analysis of the discordance between radiographic changes and knee pain in osteoarthritis of the knee. J. Rheumatol. 27, 1513–1517 (2000).PubMed

70.

Soto-Hermida, A. et al. Mitochondrial DNA haplogroups modulate the radiographic progression of Spanish patients with osteoarthritis. Rheumatol. Int. 35, 337–344 (2015).PubMedCrossRef

71.

Soto-Hermida, A. et al. Mitochondrial DNA (mtDNA) haplogroups influence the progression of knee osteoarthritis. Data from the Osteoarthritis Initiative (OAI). PLoS ONE 9, e112735 (2014).PubMedPubMedCentralCrossRef

72.

Wesseling, J. et al. CHECK (Cohort Hip and Cohort Knee): similarities and differences with the Osteoarthritis Initiative. Ann. Rheum. Dis. 68, 1413–1419 (2009).PubMedCrossRef

73.

Fernandez-Moreno, M. et al. Mitochondrial haplogroups define two phenotypes of osteoarthritis. Front. Physiol. 3, 129 (2012).PubMedPubMedCentralCrossRef

74.

Rego-Perez, I. et al. Mitochondrial DNA haplogroups modulate the serum levels of biomarkers in patients with osteoarthritis. Ann. Rheum. Dis. 69, 910–917 (2010).PubMedCrossRef

75.

Rego-Perez, I. et al. Mitochondrial DNA haplogroups and serum levels of proteolytic enzymes in patients with osteoarthritis. Ann. Rheum. Dis. 70, 646–652 (2011).PubMedCrossRef

76.

Valdes, A. M. & Goldring, M. B. Mitochondrial DNA haplogroups and ageing mechanisms in osteoarthritis. Ann. Rheum. Dis. 76, 939–941 (2017).PubMedCrossRef

77.

Glyn-Jones, S. et al. Osteoarthritis. Lancet 386, 376–387 (2015).PubMedCrossRef

78.

Visser, A. W. et al. The relative contribution of mechanical stress and systemic processes in different types of osteoarthritis: the NEO study. Ann. Rheum. Dis. 74, 1842–1847 (2015).PubMedCrossRef

79.

Yusuf, E. et al. Association between weight or body mass index and hand osteoarthritis: a systematic review. Ann. Rheum. Dis. 69, 761–765 (2010).PubMedCrossRef

80.

Choi, C. H. J. & Cohen, P. Adipose crosstalk with other cell types in health and disease. Exp. Cell Res. 360, 6–11 (2017).PubMedCrossRef

81.

Azamar-Llamas, D., Hernández-Molina, G., Ramos-Ávalos, B. & Furuzawa-Carballeda, J. Adipokine contribution to the pathogenesis of osteoarthritis. Mediators Inflamm. 2017, 5468023 (2017).PubMedPubMedCentralCrossRef

82.

Scotece, M. et al. Adipokines as drug targets in joint and bone disease. Drug Discov. Today 19, 241–258 (2014).PubMedCrossRef

83.

Nardelli, C. et al. Haplogroup T is an obesity risk factor: mitochondrial DNA haplotyping in a morbid obese population from southern Italy. Biomed. Res. Int. 2013, 631082 (2013).PubMedPubMedCentralCrossRef

84.

Ebner, S. et al. Mitochondrial haplogroup T is associated with obesity in Austrian juveniles and adults. PLoS ONE 10, e0135622 (2015).PubMedPubMedCentralCrossRef

85.

Yang, T. L. et al. Genetic association study of common mitochondrial variants on body fat mass. PLoS ONE 6, e21595 (2011).PubMedPubMedCentralCrossRef

86.

Knoll, N. et al. Mitochondrial DNA variants in obesity. PLoS ONE 9, e94882 (2014).PubMedPubMedCentralCrossRef

87.

Alé, A., Zhang, Y., Han, C. & Cai, D. Obesity-associated extracellular mtDNA activates central TGFβ pathway to cause blood pressure increase. Am. J. Physiol. Endocrinol. Metab. 312, E161–E174 (2017).PubMedCrossRef

88.

Heinonen, S. et al. Mitochondria-related transcriptional signature is downregulated in adipocytes in obesity: a study of young healthy MZ twins. Diabetologia 60, 169–181 (2017).PubMedCrossRef

89.

Cheng, Y. J. et al. Prevalence of diagnosed arthritis and arthritis-attributable activity limitation among adults with and without diagnosed diabetes: United States, 2008–2010. Diabetes Care 35, 1686–1691 (2012).PubMedPubMedCentralCrossRef

90.

Williams, M. F., London, D. A., Husni, E. M., Navaneethan, S. & Kashyap, S. R. Type 2 diabetes and osteoarthritis: a systematic review and meta-analysis. J. Diabetes Complications 30, 944–950 (2016).PubMedCrossRef

91.

Rosa, S. C. et al. Expression and function of the insulin receptor in normal and osteoarthritic human chondrocytes: modulation of anabolic gene expression, glucose transport and GLUT-1 content by insulin. Osteoarthritis Cartilage 19, 719–727 (2011).PubMedCrossRef

92.

Gugliucci, A. Formation of fructose-mediated advanced glycation end products and their roles in metabolic and inflammatory diseases. Adv. Nutr. 8, 54–62 (2017).PubMedPubMedCentralCrossRef

93.

Larkin, D. J. et al. Inflammatory markers associated with osteoarthritis after destabilization surgery in young mice with and without receptor for advanced glycation end-products (RAGE). Front. Physiol. 4, 121 (2013).PubMedPubMedCentralCrossRef

94.

Abella, V. et al. Adipokines, metabolic syndrome and rheumatic diseases. J. Immunol. Res. 2014, 343746 (2014).PubMedPubMedCentralCrossRef

95.

Feder, J. et al. Parental diabetes status reveals association of mitochondrial DNA haplogroup J1 with type 2 diabetes. BMC Med. Genet. 10, 60 (2009).PubMedPubMedCentralCrossRef

96.

Marom, S., Friger, M. & Mishmar, D. MtDNA meta-analysis reveals both phenotype specificity and allele heterogeneity: a model for differential association. Sci. Rep. 7, 43449 (2017).PubMedPubMedCentralCrossRef

97.

Kuo, H. M. et al. Altered mitochondrial dynamics and response to insulin in cybrid cells harboring a diabetes-susceptible mitochondrial DNA haplogroup. Free Rad. Biol. Med. 96, 116–129 (2016).PubMedCrossRef

98.

Chinnery, P. F. et al. Mitochondrial DNA haplogroups and type 2 diabetes: a study of 897 cases and 1010 controls. J. Med. Genet. 44, e80 (2007).PubMedPubMedCentralCrossRef

99.

Estopinal, C. B. et al. Mitochondrial haplogroups are associated with severity of diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 55, 5589–5595 (2014).PubMedPubMedCentralCrossRef

100.

Bregman, J. A. et al. Mitochondrial haplogroups affect severity but not prevalence of diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 58, 1346–1351 (2017).PubMedPubMedCentralCrossRef

101.

Sellam, J. & Berenbaum, F. The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis. Nat. Rev. Rheumatol. 6, 625–635 (2010).PubMedCrossRef

102.

Goldring, M. B. & Otero, M. Inflammation in osteoarthritis. Curr. Opin. Rheumatol. 23, 471–478 (2011).PubMedPubMedCentralCrossRef

103.

Goldring, M. B. et al. Roles of inflammatory and anabolic cytokines in cartilage metabolism: signals and multiple effectors converge upon MMP-13 regulation in osteoarthritis. Eur. Cell. Mater. 21, 202–220 (2011).PubMedPubMedCentralCrossRef

104.

Zhang, Q. et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464, 104–107 (2010).PubMedPubMedCentralCrossRef

105.

Escames, G. et al. Mitochondrial DNA and inflammatory diseases. Hum. Genet. 131, 161–173 (2012).PubMedCrossRef

106.

Tang, S. et al. Increased IL-33 in synovial fluid and paired serum is associated with disease activity and autoantibodies in rheumatoid arthritis. Clin. Dev. Immunol. 2013, 985301 (2013).PubMedPubMedCentral

107.

Loeser, R. F. et al. Microarray analysis reveals age-related differences in gene expression during the development of osteoarthritis in mice. Arthritis Rheum. 64, 705–717 (2012).PubMedPubMedCentralCrossRef

108.

Atilano, S. R. et al. Mitochondrial DNA variants can mediate methylation status of inflammation, angiogenesis and signaling genes. Hum. Mol. Genet. 24, 4491–4503 (2015).PubMedPubMedCentralCrossRef

109.

Bougault, C. et al. Stress-induced cartilage degradation does not depend on the NLRP3 inflammasome in human osteoarthritis and mouse models. Arthritis Rheum. 64, 3972–3981 (2012).PubMedCrossRef

110.

Nakahira, K. et al. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat. Immunol. 12, 222–230 (2011).PubMedCrossRef

111.

Zhou, R., Yazdi, A. S., Menu, P. & Tschopp, J. A role for mitochondria in NLRP3 inflammasome activation. Nature 469, 221–225 (2011).PubMedCrossRef

112.

Lepetsos, P. & Papavassiliou, A. G. ROS/oxidative stress signaling in osteoarthritis. Biochim Biophys. Acta 1862, 576–591 (2016).PubMedCrossRef

113.

Jones, D. P. Radical-free biology of oxidative stress. Am. J. Physiol. Cell Physiol. 295, C849–C868 (2008).PubMedPubMedCentralCrossRef

114.

Henrotin, Y. E., Bruckner, P. & Pujol, J. P. The role of reactive oxygen species in homeostasis and degradation of cartilage. Osteoarthritis Cartilage 11, 747–755 (2003).PubMedCrossRef

115.

Henrotin, Y., Kurz, B. & Aigner, T. Oxygen and reactive oxygen species in cartilage degradation: friends or foes? Osteoarthritis Cartilage 13, 643–654 (2005).PubMedCrossRef

116.

Marcuello, A. et al. Human mitochondrial variants influence on oxygen consumption. Mitochondrion 9, 27–30 (2009).PubMedCrossRef

117.

Zhang, J. et al. Strikingly higher frequency in centenarians and twins of mtDNA mutation causing remodeling of replication origin in leukocytes. Proc. Natl Acad. Sci. USA 100, 1116–1121 (2003).PubMedPubMedCentralCrossRef

118.

Vidal-Bralo, L. et al. Specific premature epigenetic aging of cartilage in osteoarthritis. Aging 8, 2222–2231 (2016).PubMedPubMedCentralCrossRef

119.

Goldring, M. B. Chondrogenesis, chondrocyte differentiation, and articular cartilage metabolism in health and osteoarthritis. Ther. Adv. Musculoskelet. Dis. 4, 269–285 (2012).PubMedPubMedCentralCrossRef

120.

Valdes, A. M., Glass, D. & Spector, T. D. Omics technologies and the study of human ageing. Nat. Rev. Genet. 14, 601–607 (2013).PubMedCrossRef

121.

Sun, N., Youle, R. J. & Finkel, T. The mitochondrial basis of aging. Mol. Cell 61, 654–666 (2016).PubMedPubMedCentralCrossRef

122.

Greene, M. A. & Loeser, R. F. Aging-related inflammation in osteoarthritis. Osteoarthritis Cartilage 23, 1966–1971 (2015).PubMedPubMedCentralCrossRef

123.

Loeser, R. F., Collins, J. A. & Diekman, B. O. Ageing and the pathogenesis of osteoarthritis. Nat. Rev. Rheumatol. 12, 412–420 (2016).PubMedPubMedCentralCrossRef

124.

Cesari, M. et al. Sarcopenia, obesity, and inflammation — results from the Trial of Angiotensin Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors study. Am. J. Clin. Nutr. 82, 428–434 (2005).PubMedCrossRef

125.

Fu, Y. et al. Aging promotes sirtuin 3-dependent cartilage superoxide dismutase 2 acetylation and osteoarthritis. Arthritis Rheumatol. 68, 1887–1898 (2016).PubMedPubMedCentralCrossRef

126.

Hirschey, M. D., Shimazu, T., Huang, J. Y. & Verdin, E. Acetylation of mitochondrial proteins. Methods Enzymol. 457, 137–147 (2009).PubMedCrossRef

127.

D’Aquila, P., Rose, G., Panno, M. L., Passarino, G. & Bellizzi, D. SIRT3 gene expression: a link between inherited mitochondrial DNA variants and oxidative stress. Gene 497, 323–329 (2012).PubMedCrossRef

128.

Payne, B. A. & Chinnery, P. F. Mitochondrial dysfunction in aging: much progress but many unresolved questions. Biochim. Biophys. Acta 1847, 1347–1353 (2015).PubMedPubMedCentralCrossRef

129.

Kim, J. et al. Mitochondrial DNA damage is involved in apoptosis caused by pro-inflammatory cytokines in human OA chondrocytes. Osteoarthritis Cartilage 18, 424–432 (2010).PubMedCrossRef

130.

Reed, K. N., Wilson, G., Pearsall, A. & Grishko, V. I. The role of mitochondrial reactive oxygen species in cartilage matrix destruction. Mol. Cell. Biochem. 397, 195–201 (2014).PubMedCrossRef

131.

Ferrington, D. A. et al. Increased retinal mtDNA damage in the CFH variant associated with age-related macular degeneration. Exp. Eye Res. 145, 269–277 (2016).PubMedPubMedCentralCrossRef

132.

Krzywanski, D. M. et al. Endothelial cell bioenergetics and mitochondrial DNA damage differ in humans having African or West Eurasian maternal ancestry. Circ. Cardiovasc. Genet. 9, 26–36 (2016).PubMedPubMedCentralCrossRef

133.

Ross, O. A. et al. Mitochondrial DNA polymorphism: its role in longevity of the Irish population. Exp. Gerontol. 36, 1161–1178 (2001).PubMedCrossRef

134.

Raule, N. et al. The co-occurrence of mtDNA mutations on different oxidative phosphorylation subunits, not detected by haplogroup analysis, affects human longevity and is population specific. Aging Cell 13, 401–407 (2014).PubMedCrossRef

135.

Domínguez-Garrido, E. et al. Association of mitochondrial haplogroup J and mtDNA oxidative damage in two different North Spain elderly populations. Biogerontology 10, 435–442 (2009).PubMedCrossRef

136.

Rea, I. M. et al. Mitochondrial J haplogroup is associated with lower blood pressure and anti-oxidant status: findings in octo/nonagenarians from the BELFAST Study. Age 35, 1445–1456 (2013).PubMedCrossRef

137.

Fernandez-Moreno, M. et al. mtDNA haplogroup J modulates telomere length and nitric oxide production. BMC Musculoskelet. Disord. 12, 283 (2011).PubMedPubMedCentralCrossRef

138.

Maruszak, A., Canter, J. A., Styczynska, M., Zekanowski, C. & Barcikowska, M. Mitochondrial haplogroup H and Alzheimer’s disease — is there a connection? Neurobiol. Aging 30, 1749–1755 (2009).PubMedCrossRef

139.

Gaweda-Walerych, K. & Zekanowski, C. The impact of mitochondrial DNA and nuclear genes related to mitochondrial functioning on the risk of Parkinson’s disease. Curr. Genom. 14, 543–559 (2013).CrossRef

140.

Blein, S. et al. An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers. Breast Cancer Res. 17, 61 (2015).PubMedPubMedCentralCrossRef

141.

Tranah, G. J. Mitochondrial-nuclear epistasis: implications for human aging and longevity. Ageing Res. Rev. 10, 238–252 (2011).PubMedCrossRef

142.

Warner, S. C. & Valdes, A. M. Genetic association studies in osteoarthritis: is it fairytale? Curr. Opin. Rheumatol. 29, 103–109 (2017).PubMedCrossRef

143.

Roach, H. I. et al. Association between the abnormal expression of matrix-degrading enzymes by human osteoarthritic chondrocytes and demethylation of specific CpG sites in the promoter regions. Arthritis Rheum. 52, 3110–3124 (2005).PubMedCrossRef

144.

Reynard, L. N. & Loughlin, J. Genetics and epigenetics of osteoarthritis. Maturitas 71, 200–204 (2012).PubMedCrossRef

145.

Hashimoto, K. et al. Regulated transcription of human matrix metalloproteinase 13 (MMP13) and interleukin-1β (IL1B) genes in chondrocytes depends on methylation of specific proximal promoter CpG sites. J. Biol. Chem. 288, 10061–10072 (2013).PubMedPubMedCentralCrossRef

146.

Fernández-Tajes, J. et al. Genome-wide DNA methylation analysis of articular chondrocytes reveals a cluster of osteoarthritic patients. Ann. Rheum. Dis. 73, 668–677 (2014).PubMedCrossRef

147.

Rushton, M. et al. Characterization of the cartilage DNA methylome in knee and hip osteoarthritis. Arthritis Rheumatol. 66, 2450–2460 (2014).PubMedPubMedCentralCrossRef

148.

Horan, M. P. & Cooper, D. N. The emergence of the mitochondrial genome as a partial regulator of nuclear function is providing new insights into the genetic mechanisms underlying age-related complex disease. Hum. Genet. 133, 435–458 (2014).PubMedCrossRef

149.

Bellizzi, D., D’Aquila, P., Giordano, M., Montesanto, A. & Passarino, G. Global DNA methylation levels are modulated by mitochondrial DNA variants. Epigenomics 4, 17–27 (2012).PubMedCrossRef

150.

Schroeder, E. A., Raimundo, N. & Shadel, G. S. Epigenetic silencing mediates mitochondria stress-induced longevity. Cell Metab. 17, 954–964 (2013).PubMedPubMedCentralCrossRef

Medicine Matters Rheumatology

Abstract